TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 96 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $541,000 | +33.3% | 7,459 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $406,000 | -20.5% | 7,459 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $511,000 | +10.6% | 7,459 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $462,000 | -30.4% | 7,459 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $664,000 | +17.1% | 7,459 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $567,000 | -47.6% | 7,459 | -40.2% | 0.00% | -20.0% |
| Q2 2019 | $1,083,000 | +49.4% | 12,465 | +49.3% | 0.01% | 0.0% |
| Q4 2018 | $725,000 | +2238.7% | 8,347 | +2682.3% | 0.01% | – |
| Q4 2017 | $31,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $31,000 | -8.8% | 300 | 0.0% | 0.00% | – |
| Q2 2017 | $34,000 | -66.7% | 300 | -54.5% | 0.00% | -100.0% |
| Q4 2015 | $102,000 | – | 660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 94,031 | $10,164,000 | 2.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 20,530 | $2,219,000 | 1.88% |
| Strategic Global Advisors, LLC | 72,308 | $7,816,000 | 1.64% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $3,074,000 | 0.95% |
| Freestone Capital Holdings, LLC | 129,757 | $14,025,000 | 0.83% |
| Hudson Capital Management LLC | 12,394 | $1,339,667,000 | 0.82% |
| FORT, L.P. | 19,158 | $2,071,000 | 0.42% |
| MENTA CAPITAL LLC | 6,880 | $744,000 | 0.32% |
| Empirical Finance, LLC | 9,511 | $1,028,000 | 0.26% |
| ALGERT GLOBAL LLC | 4,071 | $440,000 | 0.25% |